The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Clinical trials sponsored by The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School, explained in plain language.
-
New combo drug shows promise for fatty liver in diabetes patients
Disease control ENROLLING_BY_INVITATIONThis study compares a combination diabetes drug (iGlarLixi) to insulin alone to see which better reduces liver fat in people with type 2 diabetes and fatty liver disease. About 36 participants will take the assigned treatment for 12 weeks. The goal is to find a better way to mana…
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 17, 2026 03:27 UTC
-
Blood-Cleansing therapy tested in thousands of poisoning patients
Disease control OngoingThis study looks at whether treatments that clean the blood (like dialysis or plasma exchange) can help people survive acute poisoning. Over 5,000 patients aged 12 and older in China took part. Researchers compared those who received blood-cleansing treatments to those who did no…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Diabetes pills may boost brain power in new trial
Disease control OngoingThis study tests three common diabetes medications (liraglutide, empagliflozin, and linagliptin) to see if they can improve memory and thinking in people with type 2 diabetes who have mild cognitive impairment. About 396 adults aged 40-75 will take one of the drugs for 48 weeks, …
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Immune cell boost shows promise for Late-Stage cancers
Disease control OngoingThis early-phase study tests a new immune cell therapy (memory NK cells) combined with standard treatment for people with advanced solid tumors that have spread. The main goal is to check safety in a small group of 6 patients. If safe, more patients may join to see if the therapy…
Phase: PHASE1, PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Needles for the brain: electroacupuncture trial targets memory and mood in seniors
Symptom relief OngoingThis study tests whether electroacupuncture (a type of acupuncture with mild electric current) can improve memory and mood in adults aged 60-80 who have subjective cognitive decline (feeling like memory is slipping) and depression. 86 participants will receive either real or sham…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated May 17, 2026 03:23 UTC
-
Stem cell eye drops offer new hope for dry eye sufferers
Symptom relief OngoingThis early-phase study tests whether stem cell eye drops can safely relieve dry eye symptoms in women aged 40-60 who did not get better with standard artificial tears. Ten participants use the drops twice daily for two weeks and are followed for three months. The study focuses on…
Phase: EARLY_PHASE1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated May 13, 2026 16:03 UTC
-
Robot takes on gallstones: could it make a risky procedure safer for doctors?
Symptom relief OngoingThis study compares a new robotic system to the standard method for removing gallstones from the common bile duct. The robot aims to reduce radiation exposure and physical strain on doctors during the procedure. About 200 adults with common bile duct stones will be randomly assig…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated May 04, 2026 16:22 UTC
-
Blood test may predict organ damage in diquat poisoning
Knowledge-focused OngoingThis study looks at how the amount of diquat in a person's blood relates to their risk of organ damage after poisoning. Researchers are studying 193 people who swallowed diquat to better predict who is most at risk. The goal is to improve how doctors assess and treat this dangero…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated May 17, 2026 03:28 UTC